Heute nimmt Prof. Dr. Thomas Klockgether Abschied von der Klinik für Neurologie und dem Universitätsklinikum Bonn (UKB). Über 26 Jahre prägte der Experte für Ataxien die Neurologie am UKB und brachte deren Spezialisierung voran. So wird jetzt aus der Klinik ein Zentrum mit fünf spezialisierten Abteilungen.
from Pressemitteilungen – idw – Informationsdienst Wissenschaft https://ift.tt/HSUzlNF
Martin Empting works towards the development of new active substances that can be used to treat bacterial and viral infections. He has now been awarded the Young Medicinal Chemist in Academia Prize by the European Federation of Medicinal Chemistry (EFMC) as a runner-up. This prize is aimed at young chemists who are pursuing a career in academic research.
Martin Empting works towards the development of new active substances that can be used to treat bacterial and viral infections. He has now been awarded the Young Medicinal Chemist in Academia Prize by the European Federation of Medicinal Chemistry (EFMC) as a runner-up. This prize is aimed at young chemists who are pursuing a career in academic research.